GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Additional Paid-In Capital

4basebio (LSE:4BB) Additional Paid-In Capital : £0.71 Mil(As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Additional Paid-In Capital?


4basebio's quarterly additional paid-in capital stayed the same from Jun. 2022 (£0.71 Mil) to Dec. 2022 (£0.71 Mil) and stayed the same from Dec. 2022 (£0.71 Mil) to Jun. 2023 (£0.71 Mil).

4basebio's annual additional paid-in capital stayed the same from Dec. 2020 (£0.71 Mil) to Dec. 2021 (£0.71 Mil) and stayed the same from Dec. 2021 (£0.71 Mil) to Dec. 2022 (£0.71 Mil).

4basebio Additional Paid-In Capital Historical Data

The historical data trend for 4basebio's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Additional Paid-In Capital Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Additional Paid-In Capital
- 0.71 0.71 0.71

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Additional Paid-In Capital Get a 7-Day Free Trial 0.71 0.71 0.71 0.71 0.71

4basebio Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

4basebio Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of 4basebio's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (LSE:4BB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Additional Paid-In Capital
Comparable Companies
LSE:ETX LSE:AREC LSE:OBD LSE:DEST LSE:SBTX LSE:SAR LSE:FUM LSE:TRX LSE:REDX LSE:C4XD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
88Q:Germany
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
Website
https://www.4basebio.com
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines